HomeEXECUTIVESJack Wang Ph.D. Appointed to Pressao Medical BOD: An Accomplished Business Leader

Jack Wang Ph.D. Appointed to Pressao Medical BOD: An Accomplished Business Leader

September 23, 2020

Jack Wang, Ph.D. has been appointed to the Board of Directors of Pressao Medical. Wang is an accomplished business leader with more than 20 years’ experience in the medical device industry (including Biosensors International, Johnson & Johnson and Guidant Corporation) with a successful track record in business execution and exits.

Currently, Jack is the chairman and CEO of HeMo Bioengineering Limited, a medical device company established in 2017, primarily focusing on neurovascular intervention in Asia, with its current manufacturing and marketing and sales headquarters in China. Previously, Jack was the CEO of Biosensors International, a pioneer in interventional cardiology devices, where he was responsible for the company’s significant growth and strategic direction leading to the acquisition of several successful companies.

A graduate of Case Western Reserve University, Jack has been granted more than 20 U.S. and European patents in medical devices and technology and has published more than 30 scientific papers on polymer materials and processing.

“We are excited to welcome Dr. Jack Wang to our board. His unique combination of vast industry experience and perspective will be critical as we prepare for international market entry,” says Shawn Moaddeb, the chairman of Pressao Medical.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

Gynesonics Announces FDA Clearance of Next Generation Sonata System

“This clearance brings significant system improvements that expand the location of fibroids that can be treated while allowing the physician to control all aspects of the treatment from within the sterile field,” said Jiayu Chen, Ph.D. Vice President, Engineering and Advanced Technologies at Gynesonics.

Blackrock Neurotech Invests In Groundbreaking Auditory Nerve Implant With University Of Minnesota And MED-EL

The new investment will enable the development and translation of a new ANI through preclinical studies and later, a pilot clinical trial, where the ANI is then implanted in up to three deaf patients.

Jonathan Chapman: New President/CEO of Trividia Health

Chapman said, “I’m honored to join the Trividia team as President and CEO. This organization has a long history of leadership within the healthcare industry as a provider of accurate, accessible, and affordable point-of-care solutions for the management of diabetes.”

SOLOPASS® System (Bedside Neuro-Navigation Device) Receives FDA 510(k) Clearance

inTRAvent’s SOLOPASS® system brings simple, portable, bedside neuro-navigation into the intensive care unit.

Skyhawk Therapeutics Completes New Investment Round

A $133 million round of investment will allow Skyhawk to accelerate development of its novel small molecule RNA-modifying drug candidates into the clinic.

By using this website you agree to accept Medical Device News Magazine Privacy Policy